Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease.

Literature DB >> 1790407

Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease.

J A Kanis¹, P Geusens, C Christiansen.

Abstract

Entities: Disease

Mesh：

Year: 1991 PMID： 1790407 DOI： 10.1007/bf01625451

Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

1. An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines.

Authors: R Baddoura; H Awada; J Okais; M Salamoun; G Ayoub; N Ziadé; G El Hajj-Fuleihan
Journal: Osteoporos Int Date: 2006-05-03 Impact factor: 4.507

2. Quality of life and vertebral osteoporosis.

Authors: J A Kanis; W H Minne; P J Meunier; R Ziegler; E Allender
Journal: Osteoporos Int Date: 1992-07 Impact factor: 4.507

3. Calcitonin versus etidronate for the treatment of postmenopausal osteoporosis: a meta-analysis of published clinical trials.

Authors: J M Cardona; E Pastor
Journal: Osteoporos Int Date: 1997 Impact factor: 4.507

Review 4. How Long to Treat with Denosumab.

Authors: Aline G Costa; John P Bilezikian
Journal: Curr Osteoporos Rep Date: 2015-12 Impact factor: 5.096

5. Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.

Authors: P Lips; C Cooper; D Agnusdei; F Caulin; P Egger; O Johnell; J A Kanis; U Liberman; H Minne; J Reeve; J Y Reginster; M C de Vernejoul; I Wiklund
Journal: Osteoporos Int Date: 1997 Impact factor: 4.507

Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease.

1. An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines.

2. Quality of life and vertebral osteoporosis.

3. Calcitonin versus etidronate for the treatment of postmenopausal osteoporosis: a meta-analysis of published clinical trials.

Review 4. How Long to Treat with Denosumab.

5. Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.

6. Long-term performance in vitro and in vivo of dual-energy X-ray absorptiometry.

Review 7. What constitutes evidence for drug efficacy in osteoporosis?

8. Precision and accuracy of in vivo bone mineral measurement in rats using dual-energy X-ray absorptiometry.

Review 9. Rationale for the use of alendronate in osteoporosis.

Review 10. The impact of fragility fracture on health-related quality of life : the importance of antifracture therapy.